Increase in G(iα) protein accompanies progression of post-infarction remodeling in hypertensive cardiomyopathy

Hypertension

Volumn 36, Issue 1, 2000, Pages 42-47

  Kouchi, Ichiro ^c   Zolk, Oliver ^c   Jockenhövel, Friedrich ^c   Itter, Gabi ^a   Linz, Wolfgang ^a   Cremers, Bodo ^c   Böhm, Michael ^b  

^a SANOFI   (France)

^b UNIVERSITY OF COLOGNE   (Germany)

^c NONE

Author keywords

Atrial natriuretic factor; Cardiomegaly; G proteins; Myocardial infarction; Ventricular remodeling

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; CARDIOMYOPATHY; CORONARY ARTERY LIGATION; CORRELATION FUNCTION; DRESSLER SYNDROME; HEART VENTRICLE REMODELING; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0033866027     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.36.1.42     Document Type: Article

References (31)

1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
2. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Cire Res. 1979;44:503-512.
3. Goldman S, Raya TE. Rat infarct model of myocardial infarction and heart failure. J Card Fail. 1995;1:169-177.
4. Stokes J, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease: the Framingham Study: 30 years of follow-up. Hypertension. 1989;13(suppl I):I13-I18.
5. Boluyt MO, Bing OH, Lakatta EG. The aging spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur Heart J. 1995;16(suppl N): 19-30.
6. Cohn JN. The sympathetic nervous system in heart failure. J Cardiovasc Pharmacol. 1989;14(suppl 5):S57-S61.
7. iα-proteins in prehypertensive and hypertensive spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1994;23: 980-987.
8. Vantrimpont P, Rouleau JL, Ciampi A, Harel F, de Champlain J, Bichet D, Moye LA, Pfeffer M. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. Eur Heart J. 1998;19:1552-1563.
9. Yamamoto J, Ohyanagi M, Monta M, Iwasaki T. Beta-adrenoceptor-G protein-adenylate cyclase complex in rat hearts with ischemic heart failure produced by coronary artery ligation. J Mol Cell Cardial. 1994; 26:617-626.
10. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988;82:189-197.
11. iα in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 1990;82:1249-1265.
12. iα in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. J Mol Cell Cardiol. 1994;26:133-149.
13. Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension: man and rat. Circ Res. 1981;48:309-319.
14. Linz W, Wohlfart P, Schölkens BA, Becker RHA, Malinski T, Wiemer G. Late treatment with ramipril increases survival in old spontaneously hypertensive rats. Hypertension. 1999;34:291-295.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
16. Böhm M, Zolk O, Flesch M, Schiffer F, Schnabel P, Stasch JP, Knorr A. Effects of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition on cardiac β-adrenergic signal transduction. Hypertension. 1998;31:747-754.
17. Cremers B, Flesch M, Südkamp M, Böhm M. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil. J Cardiovasc Pharmacol. 1997;29:692-696.
18. Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E. Effects of hypertension on cardiac performance in rats with myocardial infarction. Am J Cardiol. 1982;50:488-496.
19. Nishikimi T, Yamagishi H, Takeuchi K, Takeda T. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat. Cardiovasc Res. 1995;29:856-861.
20. Drexler H, Hanze J, Finckh M, Lu W, Just H, Lang RE. Atrial natriuretic peptide in a rat model of cardiac failure: atrial and ventricular mRNA, atrial content, plasma levels, and effect of volume loading. Circulation. 1989;79:620-633.
21. Ohsuzu F, Katsushika S, Maie S, Akanuma M, Yanagida S, Sakata N, Ishida H, Aosaki N, Nakamura H. Enhanced myocardial adenylate cyclase activity in spontaneously hypertensive rats. Jpn Circ J. 1992;56 301-309.
22. Atkins FL, Bing OH, DiMauro PG, Conrad CH, Robinson KG, Brooks WW. Modulation of left and right ventricular β-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure. Hypertension. 1995;26:78-82.
23. i-protein precedes the development of blood pressure in spontaneously hypertensive rats. J Mol Cell Cardiol. 1997;29:1009-1022.
24. Anand-Srivastava MB. Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats: relationship to adenylate cyclase inhibition. Biochem J. 1992;288:79-85.
25. Murakami T, Katada T, Yasuda H. Reduction in the activity of the stimulatory guanine nucleotide-binding protein in the myocardium of spontaneously hypertensive rats. J Mol Cell Cardiol. 1987;19:199-208.
26. Gu XH, Kompa AR, Summers RJ. Regulation of beta-adrenoceptors in a rat model of cardiac failure: effect of perindopril. J Cardiovasc Pharmacol. 1998;32:66-74.
27. sα in myofibroblasts localized to the infarct scar in heart failure due to myocardial infarction. Cardiovasc Res. 1999;41: 575-585.
28. Sethi R, Elimban V, Chapman D, Dixon IMC, Dhalla NS. Differential alterations in left and right ventricular G-proteins in congestive heart failure due to myocardial infarction. J Mol Cell Cardiol. 1998;30: 2153-2163.
29. iα-2 in rat heart. Circ Res. 1993;72:696-700.
30. i proteins and its physiological relevance in murine cardiac myocytes. Circ Res. 1999;84:43-52.
31. Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG. Recent advances in cardiac β2-adrenergic signal transduction. Circ Res. 1999;85: 1092-1100.